Chronic Kidney Disease Knowledge and Awareness Among American Indians
- Conditions
- Chronic Kidney Disease
- Registration Number
- NCT02309528
- Lead Sponsor
- The Cleveland Clinic
- Brief Summary
Few educational intervention clinical trials have been conducted among those at risk for or with early chronic kidney disease. To the investigators' knowledge none have used digital storytelling as a means to deliver the educational message and have been conducted among American Indians, a group with high prevalence of chronic kidney disease and end stage kidney disease.
The aims of the research project are to:
1. Quantify levels of chronic kidney disease knowledge and awareness among American Indians.
2. Determine the effectiveness of a culturally tailored health presentation with computerized digital stories made by American Indians for improving chronic kidney disease knowledge and factors thought to be preventative of chronic kidney disease or its progression at baseline and follow-up in a pilot educational clinical intervention trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- Strong Heart Study or Strong Heart Family Study participant
- End Stage Renal Disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Chronic Kidney Disease Knowledge up to 12 months Survey of CKD Knowledge at baseline, post-intervention, 1-month follow up, 6 month follow up, and 12 month follow up
- Secondary Outcome Measures
Name Time Method Blood Pressure Sept 2014-Sept 2015, baseline, 1-month, 6-month, and 12-month follow-up average resting blood pressure collected via automated BP machine which has 5 minute rest period, then collects BP at 1 minute intervals for 3 measurements, and then calculates an average
Self-reported doctor visits and hospitalizations 1-month, 6-month, and 12-month follow-up Survey collection of self-reported doctor visits or hospitalizations
Self-reported new medical conditions 1-month, 6-month, and 12-month follow-up Survey collection of self-reported new diagnoses (i.e. diabetes, hypertension)
Self-reported medication use and adherence 1-month, 6-month, and 12-month follow-up Self-reported non-steroidal anti-inflammatory use and self-reported medication adherence of diabetes and/or blood pressure medications via the Morisky Medication Adherence Scale (MMAS-4)
Trial Locations
- Locations (1)
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States